These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27553030)

  • 1. Maternal Influences on Access to and Use of Infant ARVs and HIV Health Services in Uganda.
    Bergmann JN; Wanyenze RK; Makumbi F; Naigino R; Kiene SM; Stockman JK
    AIDS Behav; 2017 Sep; 21(9):2693-2702. PubMed ID: 27553030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review.
    Gourlay A; Birdthistle I; Mburu G; Iorpenda K; Wringe A
    J Int AIDS Soc; 2013 Jul; 16(1):18588. PubMed ID: 23870277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of accessing infant HIV medications and health services in Uganda.
    Bergmann JN; Wanyenze RK; Stockman JK
    AIDS Care; 2017 Nov; 29(11):1426-1432. PubMed ID: 28521509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries.
    Stringer EM; Ekouevi DK; Coetzee D; Tih PM; Creek TL; Stinson K; Giganti MJ; Welty TK; Chintu N; Chi BH; Wilfert CM; Shaffer N; Dabis F; Stringer JS;
    JAMA; 2010 Jul; 304(3):293-302. PubMed ID: 20639563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda.
    Napyo A; Tylleskär T; Mukunya D; Tumuhamye J; Musaba MW; Ojok Arach AA; Waako P; Tumwine JK; Ndeezi G
    PLoS One; 2020; 15(10):e0240529. PubMed ID: 33057393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia.
    Okawa S; Chirwa M; Ishikawa N; Kapyata H; Msiska CY; Syakantu G; Miyano S; Komada K; Jimba M; Yasuoka J
    BMC Pregnancy Childbirth; 2015 Oct; 15():258. PubMed ID: 26459335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.
    Girma M; Wendaferash R; Shibru H; Berhane Y; Hoelscher M; Kroidl A
    Trop Med Int Health; 2017 Jun; 22(6):765-775. PubMed ID: 28407452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting adherence to short-course ARV prophylaxis for preventing mother-to-child transmission of HIV in sub-Saharan Africa: a review and lessons for future elimination.
    Colombini M; Stöckl H; Watts C; Zimmerman C; Agamasu E; Mayhew SH
    AIDS Care; 2014; 26(7):914-26. PubMed ID: 24354642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proportion of HIV exposed infants aged 0-6 months that missed nevirapine prophylaxis in Mulago National Referral Hospital, Uganda: a cross-sectional study.
    Hellen N; Joseph R; Ezekiel M; Fred S; Ronald S; Philippa M
    BMC Pediatr; 2024 Jul; 24(1):430. PubMed ID: 38965487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the Pratt pouch model of dispensing nevirapine prophylaxis on HIV exposed infant completion of 6 weeks of prophylaxis in Uganda.
    Bitarakwate E; Ashburn K; Kazooba P; Khamasi R; Natumanya E; Herrera N; Owomugisha B; Malkin RA; Kisaakye L
    PLoS One; 2021; 16(3):e0247507. PubMed ID: 33690610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of adherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Gert Sibande district in South Africa.
    Peltzer K; Mlambo M; Phaswana-Mafuya N; Ladzani R
    Acta Paediatr; 2010 May; 99(5):699-704. PubMed ID: 20146724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimate of infant HIV-free survival at 6 to 8 weeks of age due to maternal antiretroviral prophylaxis in Sub-Saharan Africa, 2004-2005.
    Boeke CE; Jackson JB
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(3):133-40. PubMed ID: 18460695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of life.
    Desmond AC; Moodley D; Conolly CA; Castel SA; Coovadia HM
    BMC Pediatr; 2015 Mar; 15():23. PubMed ID: 25885678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa.
    Stringer JS; Rouse DJ; Vermund SH; Goldenberg RL; Sinkala M; Stinnett AA
    J Acquir Immune Defic Syndr; 2000 Aug; 24(4):369-77. PubMed ID: 11015154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries.
    Sweat MD; O'Reilly KR; Schmid GP; Denison J; de Zoysa I
    AIDS; 2004 Aug; 18(12):1661-71. PubMed ID: 15280777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Operational effectiveness of single-dose nevirapine in preventing mother-to-child transmission of HIV.
    Colvin M; Chopra M; Doherty T; Jackson D; Levin J; Willumsen J; Goga A; Moodley P;
    Bull World Health Organ; 2007 Jun; 85(6):466-73. PubMed ID: 17639244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and benefits of multidrug, multidose antiretroviral therapy for prevention of mother-to-child transmission of HIV in the Dominican Republic.
    Schmidt NC; Roman-Pouriet J; Fernandez AD; Beck-Sagué CM; Leonardo-Guerrero J; Nicholas SW
    Int J Gynaecol Obstet; 2012 Mar; 116(3):219-22. PubMed ID: 22196992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass treatment with nevirapine to prevent mother-to-child transmission of HIV/AIDS in sub-Saharan African countries.
    Hashimoto H; Kapiga SH; Murata Y
    J Obstet Gynaecol Res; 2002 Dec; 28(6):313-9. PubMed ID: 12512929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention of HIV exposed infants in care at Arua regional referral hospital, Uganda: a retrospective cohort study.
    Apangu P; Izudi J; Bajunirwe F; Mulogo E; Batwala V
    BMC Public Health; 2019 Apr; 19(1):436. PubMed ID: 31023290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.